Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • cancer
  • Page 9

Tag: cancer

  • BiotechToday
  • World

EFFECT OF MISSENSE VARIATIONs: REVELEALED

bioxone November 1, 2020November 1, 2020 2

DEEPON CHAKRABORTY, UNIVERSITY OF CALCUTTA Interpretation of a large number of genetic variants identified from sequencing is one of the breakthroughs of clinical genetics. It is also termed as genetic screening. The main challenge is the identification of the effect of amino acid substituting missense variation on protein structure and function. Its several applications are […]

Read More
  • BiotechToday
  • World

Biomarker TIICs benefitting the prognosis in osteosarcoma patients

bioxone October 29, 2020October 28, 2020

Rohit Bhattacharjee, Amity University, Kolkata Osteosarcoma is a rare malignant bone tumour found in adults and children. It is characterized by early lung metastasis and poor prognosis that seriously the physical and mental health of patients. Chemotherapy and surgery include the main clinical treatment however, recurrence of metastasis remains the poor prognosis. Advances in the […]

Read More
  • BiotechToday
  • World

Human Bax-α9 – Key Player in Apoptosis

bioxone October 29, 2020October 28, 2020 1

Avipsha Datta, Rajabazar Science College, University of Calcutta The Bcl-2 family of proteins are the prime players in the mitochondrial pathway of apoptosis. Malfunctioning of 1 or more members can lead to cancers, neurodegenerative diseases and various other developmental disorders. The pro-apoptotic member BAX plays a central role in apoptosis with the assistance of mitochondrial […]

Read More
  • BiotechToday
  • World

The link between diet and Cancer

bioxone October 28, 2020October 27, 2020

Prama Ghosh, Amity University Kolkata An increased chance of cancer among those who consume large amounts of dairy products and red meat has been identified by a team of researchers at the Department of Cell Research and Immunology of Shmunis School of Biomedicine and Cancer Research at Tel Aviv University’s George S. Wise Faculty of […]

Read More
  • BiotechToday
  • World

CRISPR-Based Strategy for imaging Extrachromosomal DNA in live tumour cells

bioxone October 26, 2020October 25, 2020

Chitra Roy, University of Calcutta In 1965, a group of British oncologists viewed DNA fragments which were floating around chromosomes in cancer cells. For decades, there has been largely ignored as cellular debris. Recent advancements of technology in the field of genetics and cellular biology has paved a way for better understanding of complex diseases […]

Read More
  • BiotechToday
  • World

Is hypergastrinemia risking gastric adenocarcinoma?

bioxone October 26, 2020October 25, 2020

Arjama Roy, Amity University Kolkata Gastric adenocarcinoma is the 5th most typical cancer worldwide. The main risk factor for non-cardia gastric adenocarcinoma is atrophic gastritis. It is because of infection with Helicobacter pylori (H pylori). However, in Western populations, due to the decreasing pervasiveness of H pylori infections, the incidence of gastric adenocarcinoma has declined […]

Read More
  • BiotechToday
  • World

Genetic instability in Estrogen-exposed ovarian epithelium in association with ovarian cancer

bioxone October 25, 2020October 25, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA Loss of genomic stability prejudice genomic consistency, genetic makeup, and promote malignancies. Pathological mutations of DNA repair genes result in ovarian-cancer (OvCa). The elevation of damage burden proportionates to the elevated estrogen level, inducing DNA lesions that are dependent on the expression of hormone-receptors in G1, G2, and S phase. […]

Read More
  • BiotechToday
  • World

Gene Expression Profiling to detect Survival Prediction of Diffuse Large B-Cell Lymphoma

bioxone October 24, 2020October 23, 2020

Shreelekha Pore, National Institute of Technology, Rourkela 25% of non-Hodgkin Lymphoma includes Diffuse Large B-Cell Lymphoma (DLBCL). Through the study of cell-of-origin (COO) using gene expression profiling (GEP), DLBCL has been classified as- germinal centre B-cell-like and activated B-cell-like. Artificial intelligence is widely used for prognostic purposes for certain diseases. Machine Learning can be used […]

Read More
  • BiotechToday
  • World

Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

bioxone October 21, 2020October 21, 2020

Chitra Roy, University of Calcutta Cancer Immunotherapy work by helping the immune system to function in an efficient manner to fight cancer cells. For the immune system to start its response, it must first be able to identify and differentiate between self-part of your own body and non-self-foreign/antigen. Cancer Immunotherapy is generally divided in two […]

Read More
  • BiotechToday
  • World

A Paradigm unleashes to target Ovarian Carcinoma

bioxone October 19, 2020October 18, 2020

Chitra Roy, University of Calcutta High-Grade Serous Ovarian Carcinoma (HGSOC) is one of the most common and deadliest types of ovarian cancer. This gynaecological malignancy is a type of tumour which arises from the ovary, fallopian tube, or peritoneum. The tumour microenvironment is very complex and 40% of this tumour mass contains Macrophages. Macrophages originate […]

Read More

Posts navigation

1 … 5 6 7 8 9 10 11

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy